SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ they have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.
View all
Spero Therapeutics
Cambridge, United States · Post IPO Equity
Atomwise
San Francisco, United States · Grant
Affinivax
Cambridge, United States · Grant
Rigel Pharmaceuticals
South San Francisco, United States · IPO
Evofem Biosciences
San Diego, United States · Post IPO Equity
IsoPlexis
Branford, United States · Series D
Tasso
Seattle, United States · Series B
AVM Biotech
Seattle, United States · Grant
Quanterix
Billerica, United States · IPO
Caladrius Biosciences
Basking Ridge, United States · IPO
Ecovative Design
Green Island, United States · Series D
Summit Therapeutics
Cambridge, United States · Post IPO Equity